Juno Bio offers an at-home vaginal microbiome test that screens for bacteria, fungi and some sexually transmitted infections, and provides an analysis of microbes linked to conditions like bacterial vaginosis and yeast infections. Tests are available in 46 states and are priced at $149 for a single test or $99 for a test every three months, with patients able to book a free follow-up call with a company coach to review results and next steps. The company cites data indicating 67.5% of its customers had been incorrectly diagnosed before using the test and only 13% had been successfully treated. Juno Bio is establishing a CLIA-certified sequencing lab in Oakland to bring testing in-house, improve turnaround and support future research and clinical standardization. Founder and chief science officer Leighton Turner and CEO Hana Janebdar have framed the next phase as scaling clinical infrastructure, expanding access to actionable care and advancing understanding of the vaginal microbiome.

Total raised

$180M

Funding rounds

2

Latest round

Seed

Latest activity

Jul 2026